← Back to Research Radar
Academic Publication Academic Publication

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

730
Citations
February 1, 2025
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
48%
🔥

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

No description provided.

crossref.org › academic paper
0%

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

No description provided.

crossref.org › academic paper
0%

The effectiveness and safety of therapies for hepatocellular carcinoma with tumor thrombus in the hepatic vein, inferior vena cave and/or right atrium: a systematic review and single-arm meta-analysis

No description provided.

crossref.org › academic paper
0%

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

No description provided.

crossref.org › academic paper
0%

Feature reduction for hepatocellular carcinoma prediction using machine learning algorithms

AbstractHepatocellular carcinoma (HCC) is a highly prevalent form of liver cancer that necessitates accurate prediction models for early diagnosis and effective treatment. Machine learning algorith...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma'?

This literature focuses on:

Are there open-source GitHub repositories related to EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma?

Yes, open-source projects like slowmist/openclaw-security-practice-guide (This guide is designed for OpenClaw itself (Agent-facing), not as a traditional human-only hardening checklist.) are actively building upon these concepts.

Which startups are commercializing the technology behind EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma?

Products like JusticeFlow - AI-Powered Legal Practice are bringing this to market. Their focus is: Legal Practice Management with AI-Powered Intelligence.

What other academic literature is closely related to 'EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma'?

Yes, highly correlated activity was mapped. An entry titled 'EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma' discusses this: No description provided.

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative